Loree, J. M., Dowers, A., Tu, D., Jonker, D. J., Edelstein, D. L., Quinn, H., . . . Kopetz, S. (2020). Expanded low allele frequency RAS and BRAF V600E testing in metastatic colorectal cancer as predictive biomarkers for cetuximab in the randomized CO.17 trial. Clin Cancer Res.
Citação norma ChicagoLoree, Jonathan M., et al. "Expanded Low Allele Frequency RAS and BRAF V600E Testing in Metastatic Colorectal Cancer As Predictive Biomarkers for Cetuximab in the Randomized CO.17 Trial." Clin Cancer Res 2020.
Citação norma MLALoree, Jonathan M., et al. "Expanded Low Allele Frequency RAS and BRAF V600E Testing in Metastatic Colorectal Cancer As Predictive Biomarkers for Cetuximab in the Randomized CO.17 Trial." Clin Cancer Res 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.